Greg J Morriello

Title: Greg J Morriello: Innovator in Pharmaceutical Compounds

Introduction

Greg J Morriello is a notable inventor based in Randolph, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors and cholesterol absorption.

Latest Patents

Morriello holds 2 patents that showcase his innovative work. His latest patents include "Pyrrolidine derived beta 3 adrenergic receptor agonists," which provides compounds of Formula (I), pharmaceutical compositions thereof, and methods for treating or preventing diseases mediated by the activation of β3-adrenoceptor. Another significant patent is for "Anti-hypercholesterolemic compounds," which offers cholesterol absorption inhibitors of Formula (I) and their pharmaceutically acceptable salts and esters. These compounds are particularly useful for lowering plasma cholesterol levels, especially LDL cholesterol, and for treating and preventing atherosclerosis and related diseases.

Career Highlights

Morriello is associated with Merck Sharp & Dohme Corporation, where he continues to contribute to pharmaceutical innovations. His work has had a profound impact on the development of new treatments that address critical health issues.

Collaborations

Some of his notable coworkers include Scott D Edmondson and Richard Berger, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Greg J Morriello's contributions to pharmaceutical innovations, particularly in the areas of receptor agonists and cholesterol absorption inhibitors, highlight his role as a significant inventor in the industry. His work continues to influence the development of effective treatments for various health conditions.